CUV 0.00% $14.30 clinuvel pharmaceuticals limited

5. data and comments. 5, page-134

  1. 22,691 Posts.
    re: 5. private placement raises $7.98 million + What many have missed:

    "Dr Millen added: “Recent pre clinical results from the testing of one of our topical formulations were both unexpected and highly encouraging.

    As a consequence, EpiTan is now in the process of re-assessing its clinical trial strategy for both the subcutaneous implant and topical formulation. Details are expected to be finalised in the next few weeks.”
    _________________________________

    We could have lotions. If so, that would be more user friendly than anything.

    Perhaps a reason why the IND has been delayed.

    We'll wait for the Announcements.


    Gerry
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.